Diego Santoro joined Kite, a Gilead company, in 2021 and is General Manager and Head of the International Region.

Diego, a Brazilian pharmaceutical scientist, holds a Masters in Pharmaceutical Sciences from the University of Sao Paulo and has taken different leadership roles in his career in Commercial and in Research and Development areas. With over 20 years of experience, he has worked with renowned multinational companies such as Stiefel, GSK, Sandoz, Novartis, Gilead and Kite, specializing in Oncology for nearly a decade. Diego's current focus is Cell Therapy, and he currently manages Kite's operations in the Middle East, Southeast Asia, and Latin America. His leadership and expertise have been instrumental in advancing innovative treatments and improving patient outcomes globally.